Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Investing

Clinical trial data shows RAD 101 detects Brain Metastases

by admin February 10, 2025
February 10, 2025
Clinical trial data shows RAD 101 detects Brain Metastases

Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases

Download the PDF here.

This post appeared first on investingnews.com

previous post
6 Biggest Crypto-Mining Stocks
next post
High-Grades up to 65g/t Au at Second Fortune Gold Mine

Related Posts

A$3M Placement to Advance High-Impact Workplan for Peru

January 23, 2025

Finlay Minerals Announces Closing of Non-Brokered Private Placement...

June 10, 2025

Two Water Wells Completed & Staking Finalised at...

January 30, 2025

Argo Launches Digital Gold Investment Platform in the...

February 27, 2025

High grades incl. 10m @ 43.8g/t Au in...

June 16, 2025

Greenvale $1.8m placement to fast-track uranium exploration

March 24, 2025

Osisko Metals Intersects 0.33% Cu Over 258 Metres...

June 13, 2025

Presenting on Emerging Growth Conference 81 Day 1...

April 16, 2025

Crypto Market Recap: Utah Forwards Blockchain Bill, ByBit...

March 11, 2025

Crypto Market Recap: Swiss Central Bank Dismisses Bitcoin...

April 26, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved